Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial
Fuchs, Charles S⋅Fuchs, Charles S⋅Doi, Toshihiko⋅Doi, Toshihiko⋅Jang, Raymond W⋅Jang, Raymond W⋅Muro, Kei⋅Muro, Kei⋅Satoh, Taroh⋅Satoh, Taroh⋅Machado, Manuela⋅Machado, Manuela⋅Sun, Weijing⋅Sun, Weijing⋅Jalal, Shadia I⋅Jalal, Shadia I⋅Shah, Manish A⋅Shah, Manish A⋅Metges, Jean-Phillipe⋅Metges, Jean-Phillipe⋅Garrido, Marcelo⋅Garrido, Marcelo⋅Golan, Talia⋅Golan, Talia⋅Mandala, Mario⋅Mandala, Mario⋅Wainberg, Zev A⋅Wainberg, Zev A⋅Catenacci, Daniel V⋅Catenacci, Daniel V⋅Ohtsu, Atsushi⋅Ohtsu, Atsushi⋅Shitara, Kohei⋅Shitara, Kohei⋅Geva, Ravit⋅Geva, Ravit⋅Bleeker, Jonathan⋅Bleeker, Jonathan⋅Ko, Andrew H⋅Ko, Andrew H⋅Ku, Geoffrey⋅Ku, Geoffrey⋅Philip, Philip⋅Philip, Philip⋅Enzinger, Peter C⋅Enzinger, Peter C⋅Bang, Yung-Jue⋅Bang, Yung-Jue⋅Levitan, Diane⋅Levitan, Diane⋅Wang, Jiangdian⋅Wang, Jiangdian⋅Rosales, Minori⋅Rosales, Minori⋅Dalal, Rita P⋅Dalal, Rita P⋅Yoon, Harry H and Yoon, Harry H
JAMA Oncology, vol. 4, (no. 5), pp. e180013, 2018-05-01. | Journal Article